New Study Shows Abortion Bans Are Making Healthcare More Expensive for Women and Families

The economic ramifications of post-Roe v. Wade reproductive healthcare policies have expanded into the realm of personal finance, with a new working paper suggesting that state-level abortion bans are directly linked to an increase in out-of-pocket health insurance premiums for women of reproductive age. Released on October 5, 2026, by researchers Dr. Joelle Abramowitz and Olga Aristova, the study provides a quantitative analysis of how the shifting legal landscape following the Supreme Court’s 2022 Dobbs v. Jackson Women’s Health Organization decision has begun to reshape the financial burden of healthcare for American families.

Supported by the Center for Reproductive Rights, the research—titled "Effects of Post-Dobbs Abortion Bans on Medical Out-of-Pocket Expenditures"—utilizes data from the Current Population Survey Annual Social and Economic Supplement (CPS ASEC). By analyzing the healthcare spending of 60,000 women aged 18 to 44 between 2018 and 2024, the researchers identified a statistically significant divergence in insurance costs between states that implemented restrictive abortion policies and those that maintained legal access.

The Chronology of Legislative and Economic Shifts

The landscape of American reproductive healthcare underwent a fundamental transformation on June 24, 2022, when the Supreme Court issued its ruling in Dobbs v. Jackson. The decision overturned the nearly 50-year precedent set by Roe v. Wade, effectively returning the authority to regulate or prohibit abortion to individual state legislatures.

In the immediate aftermath, a cascade of "trigger laws" took effect across the United States, leading to near-total abortion bans in large swaths of the South and Midwest. Public health experts immediately cautioned that these legal shifts would carry significant secondary consequences. Between 2023 and 2025, reports began to surface regarding the strain on hospital resources, an increase in emergency room visits for pregnancy-related complications, and a notable rise in maternal and infant mortality rates in states with strict bans.

The current research by Abramowitz and Aristova marks a pivot in the academic discourse, shifting focus from clinical outcomes to the macroeconomic impact on insurance risk pools. The study establishes a "pre-Dobbs" baseline from 2018 to early 2022, during which time women in both restrictive and non-restrictive states reported relatively similar levels of out-of-pocket insurance spending. Following the mid-2022 ruling, the trend lines began to decouple, with women in states with abortion bans experiencing a marked increase in the financial resources required to maintain their insurance coverage.

Methodological Insights and Data Trends

The study’s methodology relies on a comparative analysis of medical expenditures. By tracking a representative sample of 60,000 women, the researchers controlled for variables such as income, age, and employment status to isolate the impact of state-level abortion policy.

The data indicates that the rising costs are not distributed uniformly. The findings highlight a disproportionate impact on Black and Hispanic women, who have historically faced greater barriers to equitable healthcare access. Researchers posit that these demographic groups are more likely to be enrolled in insurance plans that are sensitive to the "spillover effects" of state policies.

The primary mechanism identified for this cost increase is the destabilization of the risk pool. Insurance premiums are calculated based on the expected cost of care for a covered population. When abortion bans result in a higher incidence of pregnancy complications—such as sepsis, hemorrhage, or other medical emergencies that require intensive care—the aggregate cost of providing maternity care rises. When insurers face higher payouts due to these adverse outcomes, those costs are passed down to beneficiaries in the form of higher monthly premiums, deductibles, or co-pays.

Official Responses and Academic Perspectives

The release of this study has prompted discussions among healthcare economists and reproductive health advocates. Dr. Joelle Abramowitz, the lead author, emphasized that the financial burden of these policies is not merely a clinical issue but a systemic one. "The data show that women in states with abortion bans are more likely to pay out of pocket for health insurance premiums," Abramowitz stated. "Insurers may be passing costs to beneficiaries in response to increased risk imposed by the spillover effects of abortion bans, including rising maternal and infant mortality."

Rachana Desai Martin, Chief Program Officer for the Center for Reproductive Rights, framed the report as an urgent "kitchen-table issue." According to Martin, the research provides empirical evidence that the impact of abortion bans transcends the immediate inability to access a procedure, creating a ripple effect that destabilizes household budgets.

While the insurance industry has not issued a collective response to the report, analysts note that the industry generally adjusts premiums based on regional risk assessments. The increased prevalence of "high-risk" pregnancies in states where care is limited creates a measurable actuarial challenge. If pregnancy outcomes continue to deteriorate in these jurisdictions, actuaries suggest that premium volatility could persist, further complicating the financial planning of families residing in these states.

Broader Implications for the Healthcare System

The implications of these findings extend into several areas of public policy and economic health.

1. The Cost of Care Delivery: The study underscores how the legal restriction of medical procedures forces hospitals to manage more complex, emergency-level care. This shift from preventative or elective care to emergency care is inherently more expensive, creating a cost-push inflation within the healthcare system.
2. Health Equity and Economic Mobility: The disparate impact on Black and Hispanic women suggests that abortion bans are exacerbating existing wealth gaps. If women are required to allocate a larger portion of their income to insurance premiums, they have less disposable income for housing, education, or savings, effectively reducing their economic mobility.
3. Insurance Market Stability: There is a concern that if premium costs continue to rise, lower-income individuals may be forced to drop coverage entirely. A decrease in the number of insured individuals in a state often leads to a higher reliance on public health safety nets, potentially shifting the financial burden from private insurers to state and federal taxpayers.

Analyzing the Spillover Effect

The connection between abortion bans and insurance premiums is a classic example of a "spillover effect" in health economics. When the legislative environment forces clinicians to delay or withhold standard care for complications—such as miscarriage management or ectopic pregnancies—the patient’s condition often deteriorates. A patient who could have been treated with a low-cost, routine procedure may instead require an emergency surgery or extended ICU stay.

These high-cost interventions are then processed by insurance providers. In a competitive market, insurers cannot absorb these costs indefinitely. By adjusting premiums upward, insurers maintain their solvency, but they effectively penalize the entire risk pool for the increased clinical risk profile of the state.

Conclusion and Future Outlook

The working paper by Abramowitz and Aristova serves as a foundational text for understanding the secondary economic impacts of the post-Dobbs legal environment. As the legal battles over reproductive rights continue to play out in state and federal courts, the economic data suggests that the "price" of these policies is being paid in real-time by families across the country.

Future research will likely be required to determine if these cost increases will plateau or if they will continue to climb as the full, long-term health consequences of restrictive care environments become more apparent. For now, the report provides a clear indicator that reproductive healthcare policy is inextricably linked to the broader financial health of the American public, and that the consequences of these policies are being felt far beyond the doors of the clinics themselves.

The Center for Reproductive Rights has indicated that they will continue to track these economic indicators, as they represent a critical, often overlooked dimension of the debate over bodily autonomy and economic security. With the intersection of health policy and insurance economics becoming increasingly contentious, this study provides a vital metric for policymakers and the public to consider when evaluating the societal costs of restrictive reproductive legislation.